Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
Currently, Viveve Medical stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean VIVE will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems
"To sell or not to sell", if you are holding Viveve Medical shares?. Trading strategies prevent us from making rash decisions based on our personal sentiments or the buzz surrounding the market. Our trading system selects very simple strategies to guide us on when is a good time to sell our shares. Be aware that these strategies should not be used for shorting VIVE stock
A golden rule is that you must never hold a trade that leads to greater losses than those expected at the time of purchase. The moment to sell your stock always has to be determined by the stop-loss (automatic or manual)
Currently, Viveve Medical stock doesn't match any of our preferred sell setups, so if you own Viveve Medical stock and your operation is in profit probably is not time to sell now
Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock. Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal
In the last 30 days we couldn't find any rating for Viveve Medical
A favorite tool of many traders are the moving averages, that easily show trend direction. A moving average is the average price of a stock over a set period of time. Usual time periods used for moving averages are 21 days, 50 days, 100 days and 200 days
Technical analysts use supports and resistances as a way to spot price points in the stock price action that tend to work as barriers, containing the price of a stock to move up or down. A support level is a level where the price tends to find support as it falls. Price is more likely to "rebound" this level rather than break through it. Nevertheless, if the price breaks down the support, it is likely to continue falling until meeting another support level. In contrast, a resistance level is where the price may find opposition as it moves up. Likewise, the price is more likely to "rebound" at this level, and if it finally ruptures this level, the price will climb easily until it finds the next resistance
The current resistance levels are:
The current support levels are:
This is an indicator that was developed in the 1980s by John Bollinger. The Bollinger Bands are lines that fluctuate around a centralmoving averagediffering in distance from the bottom to the top depending on market volatility. They are usually drawn by an interval of two standard deviations, above and below, from a moving average line. Bollinger himself recommends the moving average period to be 20
The relative strength index (RSI) is a technical indicator used in the analysis of stock markets. It is intended to map the current and past weakness or strength of a stock or market based on the closing prices of a recent trading period. Like other oscillation indicators, the RSI fluctuates in a range between 0% and 100%. The relative strength indicator is one of the best known and most widely used indicators, invented by J. Welles Wilder in 1978
When the Relative Strength Indicator (RSI) fluctuates for so long below 70 and above 30, without signaling moments of overvaluation and undervaluation, the indicator becomes of little use, and we are currently in one of these situations.
Viveve Medical had the earnings call and posted the Q1 report in mid-May. Viveve Medical topped analysts estimates and presented earnings of %s per-share of $-0.82, that is a 93.49% surprise compared to the initial predictions of $-12.60. Reported sales were $1.3 million compared to estimates of $1.1 million.
For comparison, the EPS for the same quarter last year was $-0.22, so current EPS is a drop of -272.73%. Looking at revenues, figures dropped a -56.81% compared to $3.0M year over year.
Viveve Medical will host the quarterly earnings call on early next August. Market estimates a per-share earnings of %s of $-10.15, compared to Q1 that made $-0.82. Financial reporting day has a more than usual risk for stock traders as the results published can gap up or down the price with lower volume and not respecting your buy/stop-loss orders. You can obtain more information about the earnings call and the earnings reports on the Investor Relations section of its website: http://www.viveve.com.